Unfortunately, there is a "Jekyll and Hyde" aspect to many pharma companies today as they struggle with the dictates of shareholders and the whole blockbuster model. Nowhere was that more evident today than in two articles received within hours of each other. First, from Forbes, a piece on "How Merck Healed Itself" and got it's mojo back.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments